The Subendothelium of the HMEC-1 Cell Line Supports Thrombus Formation in the Absence of von Willebrand Factor and Collagen Types I, III and VI

Arnaud Bonnefoy; Jolan Harsfalvi; George Pfliegler; Françoise Fauvel-Lafève; Chantal Legrand

doi:10.1055/s-0037-1615620

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2001; 85(03): 552-559
DOI: 10.1055/s-0037-1615620

Review Article

Schattauer GmbH

The Subendothelium of the HMEC-1 Cell Line Supports Thrombus Formation in the Absence of von Willebrand Factor and Collagen Types I, III and VI

Arnaud Bonnefoy

¹Laboratoire “Protéines Adhésives et Protéases des Cellules Vasculaires et Sanguines”, Unité 353 INSERM, Institut d’Hématologie, Université Paris VII Denis-Diderot, Hôpital St Louis, Paris, France; Department of Clinical Biochemistry and Molecular Pathology

,

Jolan Harsfalvi

¹Laboratoire “Protéines Adhésives et Protéases des Cellules Vasculaires et Sanguines”, Unité 353 INSERM, Institut d’Hématologie, Université Paris VII Denis-Diderot, Hôpital St Louis, Paris, France; Department of Clinical Biochemistry and Molecular Pathology

,

George Pfliegler

²2^nd Department of Medicine, University of Debrecen, Debrecen, Hungary

,

Françoise Fauvel-Lafève

¹Laboratoire “Protéines Adhésives et Protéases des Cellules Vasculaires et Sanguines”, Unité 353 INSERM, Institut d’Hématologie, Université Paris VII Denis-Diderot, Hôpital St Louis, Paris, France; Department of Clinical Biochemistry and Molecular Pathology

,

Chantal Legrand

¹Laboratoire “Protéines Adhésives et Protéases des Cellules Vasculaires et Sanguines”, Unité 353 INSERM, Institut d’Hématologie, Université Paris VII Denis-Diderot, Hôpital St Louis, Paris, France; Department of Clinical Biochemistry and Molecular Pathology

› Institutsangaben

Abstract

Summary

The macromolecular composition of the extracellular matrix (ECM) produced by the human microvascular endothelial cell line (HMEC-1) was determined by ELISA and its thrombogenicity was studied in blood perfusion assays. Results were compared with those obtained with the ECM produced by human umbilical vein endothelial cells (HUVEC). The HMEC-1’s ECM contains collagen type IV, fibronectin, laminin and thrombospondin, but no detectable levels of collagen types I, III and VI, or von Willebrand factor (vWF), whereas all these components were found in the ECM synthesized by HUVEC. HMEC-1’s ECM was perfused with low-molecular-weight heparin-anticoagulated blood at two wall shear rates (650/s and 2600/s), representative of moderate and high arterial wall shear rates, in parallel plate flow chambers for 5 min. This resulted in the formation of large platelet aggregates, compared to essentially a monolayer of adherent platelets on HUVEC’s ECM. Interestingly, large thrombi were formed at 2600/s when HMEC-1’s ECM was perfused with the blood of a patient with severe type III von Willebrand disease lacking both plasma and platelet vWF, indicating that vWF was not absolutely required for thrombus formation on this matrix. Thrombin generated on the HMEC-1’s ECM contributed importantly to the large platelet thrombi formed, shown by performing blood perfusion experiments in the presence of thrombin inhibitors. Our results indicate that 1) platelet adhesion and aggregate formation on a subendothelium may occur at a high shear rate (2600/s) without the participation of collagen types I, III and VI, and vWF; and 2) the HMEC-1 cell line may prove useful for in vitro studies of the thrombogenic properties of microvascular subendothelium which in most cases does not contain fibrillar collagens and vWF.

Keywords

Thrombus formation - von Willebrand factor - collagen - HMEC-1 - shear rate - extracellular matrix (ECM)

Volltext

Referenzen

References
1 Sakariassen KS, Bolhuis PA, Sixma JJ. Human blood platelet adhesion to artery subendothelium is mediated by factor VIII/vWF bound to subendothelium. Nature (Lond.) 1979; 279: 636-8.
2 Nievelstein FEM, de Groot PG, D’Alessio P, Heijnen HFG, Orlando E, Sixma JJ. Platelet adhesion to vascular cells. The role of exogenous von Willebrand factor in platelet adhesion. Arteriosclerosis 1990; 10: 462-9.
3 Zwaginga JJ, Sixma JJ, de Groot PG. Activation of endothelial cells induces platelet thrombus formation on their matrix. Studies of new in vitro thrombosis model with low molecular weight heparin as anticoagulant. Arteriosclerosis 1990; 10: 49-61.
4 Turitto VT, Weiss HJ, Baumgartner HR. Platelet interaction with rabbit subendothelium in von Willebrand’s disease: altered thrombus formation distinct from defective platelet adhesion. J Clin Invest 1984; 74: 1730-41.
5 Moake JL, Turner NA, Stathopoulos NA, Nolasco L, Hellums JD. Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin. Blood 1988; 71: 1366-74.
6 Fressinaud E, Sakariassen KS, Rothschild C, Baumgartner HR, Meyer D. Shear rate-dependent impairment of thrombus growth on collagen in non-anticoagulated blood from patients with von Willebrand disease and hemophilia A. Blood 1992; 80: 988-94.
7 Ruggeri ZM, Dent JA, Saldivar E. Contribution of distinct adhesive interactions to platelet aggregation in flowing blood. Blood 1999; 87: 1234-40.
8 Savage B, Saldivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996; 84: 289-97.
9 Sixma JJ, van Zauten GH, Saelman EU, Verkleij M, Lankhof H, Nieuwenhuis HH, de Groot PG. Platelet adhesion to collagen. Thromb Haemost 1995; 74: 454-9.
10 Legrand YJ, Rodriguez-Zeballos A, Kartali G, Fauvel F, Caen JP. Adsorption of factor VIII antigen-activity complex by collagen. Thromb Res 1978; 13: 909-11.
11 Cruz MA, Yuan H, Lee JR, Wise RJ, Handin RI. Interaction of the von Willebrand factor (vWF) with collagen. Localization of the primary collagen-binding site by analysis of recombinant v WFA domain polypeptides. J Biol Chem 1995; 270: 10822-7.
12 Lankhof H, van Hoeij M, Schiphorst ME, Bracke M, Wu YP, Ijsseldijk MJ, Vink T, de Groot PG, Sixma JJ. A3 domain is essential for interation of von Willebrand factor with collagen type III. Thromb Haemost 1996; 75: 950-8.
13 Rand JH, Patel ND, Schwartz E, Zhou S-L, Potter BJ. 150-kD von Willebrand factor binding protein extracted from human vascular subendothelium is type VI collagen. J Clin Invest 1988; 88: 253-9.
14 Hoylaerts MF, Yamamoto H, Nuyts K, Vreys I, Deckmyn H, Vermylen J. von Willebrand factor binds to native collagen VI primarily via its A1 domain. Biochem J 1997; 324: 185-91.
15 Van Zanten GH, Saelman EUM, Schut-Hese KM, Wu YP, Slootweg PJ, Nieuwenhuis HK, de Groot PG, Sixma JJ. Platelet adhesion to collagen type IV under flow conditions. Blood 1996; 88: 3862-71.
16 Houdijk WP, Sakariassen KS, Nievelstein PF, Sixma JJ. Role of Factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagens types I and III. J Clin Invest 1985; 75: 531-40.
17 Bastida E, Escolar G, Ordinas A, Sixma JJ. Fibronectin is required for platelet adhesion and for thrombus formation on subendothelium and collagen surfaces. Blood 1987; 70: 1437-42.
18 Hindriks G, Ijsseldijk MJ, Sonnenberg A, Sixma JJ, de Groot PG. Platelet adhesion to laminin: role of Ca²⁺ and Mg²⁺ ions, shear rate, and platelet membrane glycoproteins. Blood 1992; 79: 928-35.
19 Agbanyo FR, Sixma JJ, de Groot P, Languino LR, Plow EF. Thrombospondin-platelet interactions. Role of divalent cations, wall shear rate, and platelet membrane glycoproteins. J Clin Invest 1993; 92: 288-96.
20 Sakariassen KS, Baumgartner HR. Axial dependence of platelet-collagen interactions in flowing blood. Upstream thrombus growth impairs downstream platelet adhesion. Arteriosclerosis 1989; 9: 33-42.
21 Frojmovic MM, Kasirer-Friede A, Goldsmith HL, Brown EA. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa. Thromb Haemost 1997; 7: 568-76.
22 André P, Brouland JP, Roussi J, Bonneau M, Pignaud G, Bal dit Sollier C, Hainaud P, Vaiman M, Drouet L. Role of plasma and platelet von Willebrand factor in arterial thrombogenesis and hemostasis in the pig. Exp Hematol 1998; 26: 620-6.
23 Legrand C, Thibert V, Dubernard V, Bégault B, Lawler J. Molecular requirements for the interaction of thrombospondin with thrombin-activated human platelets. Modulation of platelet aggregation. Blood 1992; 79: 1995-2003.
24 Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. J Clin Invest 1973; 52: 2745-56.
25 Tannenbaum SH, Rick ME, Shafer B, Gralnick HR. Subendothelial matrix of cultured endothelial cells contains fully processed high molecular weight von Willebrand factor. J Lab Clin Med 1989; 113: 372-8.
26 Myers JC, Howard PS, Walther SE, Gorfien SF, Macarak EJ. Collagen and fibronectin gene expression in cultured endothelial cells. Ann NY Acad Sci 1990; 580: 120-31.
27 Gerritsen ME. Functional heterogeneity of vascular endothelial cells. Biochem Pharmacol 1987; 36: 2701-11.
28 Wu QY, Drouet L, Carrier JL, Rotschild C, Berard M, Rouault C, Caen JP, Meyer D. Differential distribution of von Willebrand factor in endothelial cells. Comparison between normal pigs and pigs with von Willebrand disease. Arteriosclerosis 1987; 7: 47-54.
29 Rand JH, Badimon L, Gordon RE, Uson RR, Fuster V. Distribution of von Willebrand factor in porcine intima varies with blood vessel type and location. Arteriosclerosis 1987; 7: 287-91.
30 Yamamoto K, de Waard V, Fearns C, Loskutoff DJ. Tissue distribution and regulation of murine von Willebrand factor gene expression in vivo. Blood 1998; 92: 2791-801.
31 Yurchenco PD, Schittny JC. Molecular architecture of basement membranes. FASEB J 1990; 4: 1577-90.
32 Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC, Lawley TJ. HMEC-1: Establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 1992; 99: 683-90.
33 Xu Y, Swerlick RA, Sepp N, Bosse D, Ades EW, Lawley TJ. Characterization of expression and modulation of cell adhesion molecules on an immortalized human dermal microvascular endothelial cell line (HMEC-1). J Invest Dermatol 1994; 102: 833-7.
34 Ribeiro MJA, Phillips DJ, Benson JM, Evatt BL, Ades EW, Hooper WC. Hemostatic properties of the SV-40 transfected human microvascular endothelial cell line (HMEC-1). Thromb Res 1995; 79: 153-61.
35 Dubernard V, Legrand C. Characterization of the binding of thrombospondin to human platelets and its association with the platelet cytoskeleton. J Lab Clin Med 1991; 118: 446-57.
36 Legrand C, Dubernard V, Kieffer N, Nurden AT. Use of a monoclonal antibody to measure the surface expression of thrombospondin following platelet activation. Eur J. Biochem 1988; 171: 393-9.
37 Morandi V, Lamhamedi S, Lambert S, Fauvel-Lafeve F, Legrand Y, Legrand C. Proinflammatory cytokines (interleukin-1 and tumor necrosis factor α down regulate synthesis and secretion of thrombospondin by human endothelial cells. J Cell Physiol 1994; 160: 367-77.
38 De Groot PG, Reinders JH, Sixma JJ. Perturbation of human endothelial cells by thrombin or PMA changes the reactivity of their extracellular matrix towards platelets. J Cell Biol 1987; 104: 697-704.
39 Boda Z, Pfliegler G, Harsfalvi J, Rak K. Treatment of the severe bleeding episode in type III von Willebrand’s disease by simultaneous administration of cryoprecipitate and platelet concentrate. Blood Coag Fibrinol 1991; 2: 775-7.
40 Sakariassen KS, Aarts PAMM, de Groot PG, Houdijk WPM, Sixma JJ. A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified components. J Lab Clin Med 1983; 102: 522-35.
41 Laemmli UK. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 1970; 227: 680-5.
42 Fenton JWD, Villanueva GB, Ofosu FA, Maraganore JM. Thrombin inhibition by hirudin: how hirudin inhibits thrombin. Haemostasis 1991; 1: 27-31.
43 Sakariassen KS, Banga JD, de Groot PG, Sixma JJ. Comparison of platelet interaction with subendothelium of human and renal arteries and the extracellular matrix produced by human venous endothelial cells. Thromb Haemost 1984; 52: 60-5.
44 Zwaginga JJ, de Boer HC, Ijsseldijk MJW, Kerkhof A, Muller-Berghaus G, Gruhlichhenn J, Sixma JJ, de Groot PG. Thrombogenicity of vascular cells. Comparison between endothelial cells isolated from different sources and smooth muscle cells and fibroblasts. Arteriosclerosis 1990; 10: 437-48.
45 De Groot PG, Ottenhof-Rovers M, van Mourik JA, Sixma JJ. Evidence that the primary binding site of von Willebrand factor that mediates platelet adhesion on subendothelium is not collagen. J Clin Invest 1988; 82: 65-73.
46 Baruch D, Denis C, Marteaux C, Schoevaert D, Coulombel L, Meyer D. Role of von Willebrand factor associated to extracellular matrices in platelet adhesion. Blood 1991; 77: 519-27.
47 Tseng SCG, Savion N, Gospodarowicz D, Stern R. Characterization of collagens synthesized by cultured bovine corneal endothelial cells. J Biol Chem 1981; 256: 3361-5.
48 Vlodavsky I, Eldor A, Hyam E, Atzmon R, Fuks Z. Platelet interaction with the extracellular matrix produced by cultured endothelial cells: a model to study the thrombogenicity of isolated subendothelial basal lamina. Thromb Res 1982; 28: 179-91.
49 Varon D, Dardik R, Shenkman B, Kotev-Emeth S, Farzame N, Tamarin I, Savion N. A new method for quantitative analysis of whole blood platelet interaction with extracellular matrix under flow conditions. Thromb Res 1997; 85: 283-94.
50 Diquélou A, Lemozy S, Dupouy D, Boneu B, Sakariassen K, Cadroy Y. Effect of blood flow on thrombin generation is dependent on the nature of the thrombogenic surface. Blood 1994; 84: 2206-13.
51 Ni H, Denis CV, Subbarao S, Degen JL, Sato TN, Hynes RO, Wagner DD. Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. J Clin Invest 2000; 106: 385-92.